Complexes 2b and 2c exhibited the most potent activity against melanoma BRAF WT (MeWo) and bladder cancer (T24), with 2c showing the highest selectivity toward these cancer cell lines (selectivity index of ca. 3.0). The gene discussed is BRAF; the disease is urinary bladder cancer.